Fibrocell Science Company Profile (NASDAQ:FCSC)

About Fibrocell Science

Fibrocell Science logoFibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FCSC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.70
  • 50 Day Moving Average: $0.76
  • 200 Day Moving Average: $0.78
  • 52-Week Range: $0.52 - $3.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.49
  • P/E Growth: 0.00
  • Market Cap: $30.78M
  • Outstanding Shares: 43,978,000
  • Beta: 0.51
Profitability:
  • Net Margins: -7,362.25%
  • Return on Equity: -215.38%
  • Return on Assets: -105.48%
Debt:
  • Current Ratio: 8.80%
  • Quick Ratio: 8.80%
Additional Links:
Companies Related to Fibrocell Science:

Analyst Ratings

Consensus Ratings for Fibrocell Science (NASDAQ:FCSC) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $5.63 (703.57% upside)

Analysts' Ratings History for Fibrocell Science (NASDAQ:FCSC)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Canaccord GenuityReiterated RatingBuy$1.50View Rating Details
7/6/2016Griffin SecuritiesReiterated RatingBuy$12.00View Rating Details
6/8/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Fibrocell Science (NASDAQ:FCSC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2017        
11/3/2016Q316($0.15)($0.05)ViewN/AView Earnings Details
5/5/2016Q1($0.15)($0.03)ViewN/AView Earnings Details
3/10/2016Q415($0.17)($0.40)ViewListenView Earnings Details
11/5/2015Q315($0.16)($0.07)ViewN/AView Earnings Details
8/6/2015Q215($0.16)($0.17)ViewN/AView Earnings Details
5/8/2015($0.16)($0.17)ViewN/AView Earnings Details
3/13/2015($0.16)($0.08)ViewN/AView Earnings Details
11/7/2014Q3 14($0.14)($0.17)ViewN/AView Earnings Details
8/11/2014($0.18)($0.08)ViewN/AView Earnings Details
5/19/2014Q114($0.15)($0.35)ViewN/AView Earnings Details
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fibrocell Science (NASDAQ:FCSC)
Current Year EPS Consensus Estimate: $-0.35 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.14)($0.16)
Q2 20163($0.22)($0.09)($0.15)
Q3 20163($0.19)($0.06)($0.12)
Q4 20163($0.11)($0.07)($0.09)
Q1 20174($0.20)($0.07)($0.14)
Q2 20174($0.20)($0.07)($0.14)
Q3 20174($0.21)($0.05)($0.13)
Q4 20173($0.17)($0.05)($0.11)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Fibrocell Science (NASDAQ:FCSC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Fibrocell Science (NASDAQ:FCSC)
Insider Ownership Percentage: 1.70%
Institutional Ownership Percentage: 56.34%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2016David PernockChairmanBuy50,000$0.92$46,000.00View SEC Filing  
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Fibrocell Science (NASDAQ:FCSC)
DateHeadline
News IconPT & Stock Review on Fibrocell Science, Inc. (NASDAQ:FCSC) Ultra Clean Holdings, Inc. (NASDAQ:UCTT) - Rives Journal (NASDAQ:FCSC)
rivesjournal.com - February 24 at 6:26 PM
News IconTrading Center: Following Shares of Fibrocell Science Inc (FCSC) - The Standard (NASDAQ:FCSC)
6milestandard.com - February 24 at 6:26 PM
News IconStock Watch: Checking the Levels on Shares of Fibrocell Science, Inc. (NASDAQ:FCSC) - Baldwin Journal (NASDAQ:FCSC)
baldwinjournal.com - February 24 at 6:26 PM
News IconFibrocell Science, Inc. (NASDAQ:FCSC) Moving Higher pre-market - Aiken Advocate (NASDAQ:FCSC)
aikenadvocate.com - February 24 at 6:26 PM
News IconRevenue Update on Ultra Clean Holdings Inc(NASDAQ:UCTT) (NASDAQ:FCSC)
www.graffiotech.com - February 24 at 11:22 AM
4-traders.com logoFIBROCELL SCIENCE, INC. (NASDAQ:FCSC) Files An 8-K Other Events (NASDAQ:FCSC)
www.4-traders.com - February 23 at 5:11 PM
us.rd.yahoo.com logoFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa (NASDAQ:FCSC)
us.rd.yahoo.com - February 23 at 5:11 PM
investornewswire.com logoFibrocell Science Inc (NASDAQ:FCSC) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - February 17 at 3:44 PM
News IconAre Insiders Purchasing Their Own Shares of Fibrocell Science, Inc. (NASDAQ:FCSC)? - Winfield Review (NASDAQ:FCSC)
winfieldreview.com - February 13 at 5:59 PM
4-traders.com logoFIBROCELL SCIENCE, INC. : Change in Directors or Principal Officers (form 8-K) (NASDAQ:FCSC)
www.4-traders.com - February 13 at 9:38 AM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:FCSC)
biz.yahoo.com - February 13 at 9:38 AM
News IconFibrocell Science Inc FCSC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:FCSC)
www.bioportfolio.com - February 4 at 3:36 AM
News IconTechnical Study: Following Indicators for Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - February 1 at 10:53 PM
News IconInvestor Focus on Technical Levels for Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - January 30 at 12:09 PM
News IconFibrocell Science, Inc. FCSC Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:FCSC)
www.bioportfolio.com - January 26 at 11:38 PM
News IconMarket Rover: Looking at Levels on Shares of Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - January 26 at 6:36 PM
investornewswire.com logoStrong Sell Recommendations Of Fibrocell Science Inc (NASDAQ:FCSC) At 0 - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - January 26 at 4:36 AM
News IconIgniting Curiosity on This Name, Investor Update on Fibrocell ... - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - January 26 at 4:36 AM
News IconShares in View: Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - January 26 at 4:36 AM
News IconTrading Radar: Zooming in on Shares of Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - January 25 at 3:52 AM
News IconCan This Stock Gain Traction: Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - January 23 at 5:31 PM
News IconCheck on Average Directional Index for Fibrocell Science Inc. (FCSC) - Sherwood Daily (NASDAQ:FCSC)
sherwooddaily.com - January 19 at 3:37 AM
News IconTracking Corporate Insiders: What Are They Doing With Fibrocell Science, Inc. (NASDAQ:FCSC) - Wall Street Beacon (NASDAQ:FCSC)
wsbeacon.com - January 17 at 6:35 AM
News IconIs This Stock Ready to Rumble: Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - January 14 at 4:00 AM
investornewswire.com logoFibrocell Science Inc (NASDAQ:FCSC) Strong Sell Recommendations At {RATING_CNT_STRONG_SELLS:378}} - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - January 12 at 3:56 PM
News IconKeen Investors Taking a Look at Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - January 10 at 6:06 PM
News IconSmall Cap Concentration on Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - January 10 at 6:06 PM
marketexclusive.com logoFIBROCELL SCIENCE, INC. (NASDAQ:FCSC) Files An 8-K Other Events - Market Exclusive (NASDAQ:FCSC)
marketexclusive.com - January 10 at 6:06 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - January 9 at 5:59 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - January 9 at 5:59 PM
streetinsider.com logoFibrocell Science (FCSC) Receives FDA Fast Track Designation of FCX-007 for Treatment of RDEB - StreetInsider.com (NASDAQ:FCSC)
www.streetinsider.com - January 7 at 6:32 PM
News IconNoteworthy Stocks to Watch for: Array BioPharma Inc. (NASDAQ:ARRY), Fibrocell Science, Inc. (NASDAQ:FCSC) - The Newburgh Press (NASDAQ:FCSC)
newburghpress.com - January 7 at 3:48 AM
baystreet.ca logoFibrocell Science Receives Fast Track Designation For FCX-007, Shares Up 29% By Mid-Day - Baystreet.ca (NASDAQ:FCSC)
www.baystreet.ca - January 7 at 3:48 AM
baystreet.ca logoFibrocell Science Receives Fast Track Designation For FCX-007, Shares Up 29% By Mid-Day (NASDAQ:FCSC)
www.baystreet.ca - January 5 at 11:04 PM
streetinsider.com logoFibrocell Science (FCSC) Receives FDA Fast Track Designation of FCX-007 for Treatment of RDEB (NASDAQ:FCSC)
www.streetinsider.com - January 5 at 11:04 PM
finance.yahoo.com logo8:01 am Fibrocell Science announces FDA fast track designation of FCX-007 for treatment of recessive dystrophic epidermolysis bullosa (NASDAQ:FCSC)
finance.yahoo.com - January 5 at 6:03 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - January 5 at 6:03 PM
publicnow.com logoFibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa (NASDAQ:FCSC)
www.publicnow.com - January 5 at 6:03 PM
investornewswire.com logoCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $3? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - January 4 at 6:19 PM
News IconWatching the Numbers for Fibrocell Science, Inc. (NASDAQ:FCSC) - Wall Street Beacon (NASDAQ:FCSC)
wsbeacon.com - January 4 at 12:23 AM
News IconCheap Stock Alert on Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - December 27 at 5:20 PM
News IconPlacing This Stock in the Hotbed: Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - December 27 at 5:20 PM
News IconIs There a Catalyst Out There For Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - December 23 at 5:24 PM
News IconInvestors are Following Shares of Fibrocell Science, Inc. (NASDAQ:FCSC) - OIB News (NASDAQ:FCSC)
oibnews.com - December 21 at 9:26 AM
News IconAre There Catalysts to Propel This Stock Forward: Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - December 20 at 6:53 PM
News IconBoom or Bust? Is there any value in Fibrocell Science, Inc. (NASDAQ:FCSC) - Prospect Journal (NASDAQ:FCSC)
prospectjournal.com - December 20 at 6:53 PM
us.rd.yahoo.com logo8:06 am Fibrocell Science appoints John Maslowski as CEO and Douglas Swirsky as Chairman, succeeding David Pernock effective immediately (NASDAQ:FCSC)
us.rd.yahoo.com - December 20 at 10:16 AM
globenewswire.com logoFibrocell Announces Leadership Changes - GlobeNewswire (press release) (NASDAQ:FCSC)
globenewswire.com - December 19 at 8:34 AM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib (NASDAQ:FCSC)
biz.yahoo.com - December 19 at 8:34 AM
publicnow.com logoFibrocell Announces Leadership Changes (NASDAQ:FCSC)
www.publicnow.com - December 19 at 8:34 AM

Social

What is Fibrocell Science's stock symbol?

Fibrocell Science trades on the NASDAQ under the ticker symbol "FCSC."

Where is Fibrocell Science's stock going? Where will Fibrocell Science's stock price be in 2017?

4 brokers have issued twelve-month price targets for Fibrocell Science's shares. Their predictions range from $1.50 to $12.00. On average, they expect Fibrocell Science's stock price to reach $5.63 in the next year.

When will Fibrocell Science announce their earnings?

Fibrocell Science is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.

Who owns Fibrocell Science stock?

Fibrocell Science's stock is owned by a number of of institutional and retail investors. Top institutional investors include Third Security LLC (37.79%), FMR LLC (5.93%), MSD Partners L.P. (4.73%) and Renaissance Technologies LLC (0.44%). Company insiders that own Fibrocell Science stock include David Pernock and Randal J Kirk.

Who bought Fibrocell Science stock? Who is buying Fibrocell Science stock?

Fibrocell Science's stock was acquired by a variety of institutional investors in the last quarter, including Third Security LLC and Renaissance Technologies LLC. Company insiders that have bought Fibrocell Science stock in the last two years include David Pernock and Randal J Kirk.

How do I buy Fibrocell Science stock?

Shares of Fibrocell Science can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Fibrocell Science stock cost?

One share of Fibrocell Science stock can currently be purchased for approximately $0.70.

Fibrocell Science (NASDAQ:FCSC) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Fibrocell Science (NASDAQ:FCSC)

Earnings History Chart

Earnings by Quarter for Fibrocell Science (NASDAQ:FCSC)

Dividend History Chart

Dividend Payments by Quarter for Fibrocell Science (NASDAQ:FCSC)

Last Updated on 2/25/2017 by MarketBeat.com Staff